Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.9M | 768 | 74.0% |
| Travel and Lodging | $317,056 | 1,201 | 12.6% |
| Consulting Fee | $191,078 | 85 | 7.6% |
| Food and Beverage | $102,535 | 2,665 | 4.1% |
| Honoraria | $40,995 | 24 | 1.6% |
| Education | $1,230 | 24 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $560,530 | 697 | $0 (2024) |
| ABBVIE INC. | $453,089 | 597 | $0 (2024) |
| Amgen Inc. | $337,806 | 620 | $0 (2024) |
| Celgene Corporation | $212,028 | 344 | $0 (2019) |
| GENZYME CORPORATION | $159,655 | 279 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $124,702 | 200 | $0 (2024) |
| Janssen Biotech, Inc. | $115,489 | 297 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $113,598 | 179 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $102,909 | 152 | $0 (2019) |
| UCB, Inc. | $88,122 | 268 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472,791 | 749 | ABBVIE INC. ($161,384) |
| 2023 | $403,411 | 652 | Mallinckrodt Hospital Products Inc. ($117,349) |
| 2022 | $375,209 | 649 | Mallinckrodt Hospital Products Inc. ($133,216) |
| 2021 | $287,743 | 543 | Mallinckrodt Hospital Products Inc. ($124,055) |
| 2020 | $230,229 | 425 | Mallinckrodt Hospital Products Inc. ($85,765) |
| 2019 | $346,827 | 760 | Mallinckrodt Enterprises LLC ($72,880) |
| 2018 | $300,127 | 642 | Celgene Corporation ($101,586) |
| 2017 | $94,882 | 348 | Celgene Corporation ($44,789) |
All Payment Transactions
4,768 individual payment records from CMS Open Payments — Page 1 of 191
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $22.11 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Bone Health | ||||||
| 12/14/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $142.88 | General |
| Category: Rheumatology | ||||||
| 12/14/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Rheumatology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.30 | General |
| Category: Immunology | ||||||
| 12/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $31.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $24.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $893.54 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $893.53 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $85.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $85.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $82.79 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $41.67 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 174 | 342 | $56,575 | $34,518 |
| 2022 | 4 | 169 | 278 | $45,933 | $27,607 |
| 2021 | 7 | 218 | 343 | $50,940 | $31,495 |
| 2020 | 3 | 141 | 221 | $35,475 | $18,521 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 291 | $43,725 | $26,844 | 61.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $8,120 | $4,862 | 59.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 22 | $4,730 | $2,812 | 59.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 215 | $32,158 | $19,258 | 59.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $6,690 | $3,918 | 58.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 19 | $4,085 | $2,538 | 62.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 20 | $3,000 | $1,893 | 63.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 209 | $31,375 | $18,972 | 60.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 38 | 38 | $9,530 | $5,833 | 61.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 32 | $6,050 | $3,993 | 66.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 18 | $2,575 | $1,824 | 70.8% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 12 | 13 | $455.00 | $368.14 | 80.9% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 13 | 20 | $500.00 | $289.37 | 57.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 13 | $455.00 | $214.51 | 47.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 101 | 177 | $26,600 | $13,277 | 49.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 27 | 27 | $6,750 | $3,883 | 57.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 17 | $2,125 | $1,361 | 64.1% |
About Dr. Kostas Botsoglou, M.D
Dr. Kostas Botsoglou, M.D is a Internal Medicine healthcare provider based in Cheektowaga, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1295981652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kostas Botsoglou, M.D has received a total of $2.5M in payments from pharmaceutical and medical device companies, with $472,791 received in 2024. These payments were reported across 4,768 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.9M).
As a Medicare-enrolled provider, Botsoglou has provided services to 702 Medicare beneficiaries, totaling 1,184 services with total Medicare billing of $112,140. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Cheektowaga, NY
- Active Since 08/15/2008
- Last Updated 01/17/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295981652
Products in Payments
- ACTHAR (Biological) $663,439
- Otezla (Drug) $330,743
- RINVOQ (Biological) $244,806
- Enbrel (Biological) $134,093
- COSENTYX (Biological) $121,447
- SKYRIZI (Biological) $118,943
- SAPHNELO (Biological) $113,157
- SIMPONI ARIA (Biological) $100,634
- KEVZARA (Drug) $83,004
- TREMFYA (Drug) $62,849
- Cimzia (Drug) $62,560
- KEVZARA (Biological) $61,680
- LUPKYNIS (Drug) $31,597
- PURIFIED CORTROPHIN GEL (Drug) $19,973
- TAVNEOS (Drug) $19,704
- Crysvita (Drug) $19,257
- RINVOQ (Drug) $18,807
- CYLTEZO (Biological) $17,016
- Bimzelx (Biological) $16,183
- HUMIRA (Biological) $14,463
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cheektowaga
Mohamed Metawee, Mbbch, MBBCH
Internal Medicine — Payments: $26,519
Dr. Deirdre Bastible, Md, MD
Internal Medicine — Payments: $22,370
Eugene Kalmuk, Md, MD
Internal Medicine — Payments: $12,746
Dr. Tejinder Kalra, Md, MD
Internal Medicine — Payments: $8,769
Nawfal Alkhafaji, Md, MD
Internal Medicine — Payments: $4,758
Joseph Dipirro, M.d, M.D
Internal Medicine — Payments: $3,454